-
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8425)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 21, 2020 (publication date) through May 29, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ocker M. Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma. World J Gastroenterol 2020; 26(3): 279-290 [PMID: 31988589 DOI: 10.3748/wjg.v26.i3.279] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v26/i3/279.htm |
| Number | Citing Articles |
| 1 |
Zhaoqiang Chen, Zepeng Zhang, Jiaqi Liu, Hongyu Qi, Jing Li, Jinjin Chen, Qingxia Huang, Qing Liu, Jia Mi, Xiangyan Li. Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.853981
|
| 2 |
Zhen Yang, Lin Wang. Current, emerging, and potential therapies for non-alcoholic steatohepatitis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1152042
|
| 3 |
Magdelyn Mei-Theng Wong, Hui-Yin Chan, Norazlin Abdul Aziz, Thamil Selvee Ramasamy, Jan-Jin Bong, Ewe Seng Ch’ng, Subasri Armon, Suat-Cheng Peh, Sin-Yeang Teow. Interplay of autophagy and cancer stem cells in hepatocellular carcinoma. Molecular Biology Reports 2021; 48(4): 3695 doi: 10.1007/s11033-021-06334-9
|
| 4 |
Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, Sebastian Stintzing, Matthias Ocker. Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?. Cells 2022; 11(19): 3180 doi: 10.3390/cells11193180
|
| 5 |
Jarosław Jerzy Sak, Andrzej Prystupa, Paweł Kiciński, Dorota Luchowska-Kocot, Ewa Kurys-Denis, Hanna Bis-Wencel. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis. World Journal of Hepatology 2021; 13(12): 2071-2080 doi: 10.4254/wjh.v13.i12.2071
|
| 6 |
Manjula Nandakumar, Abu Saleh Md Moin, Manjunath Ramanjaneya, Ahmed Al Qaissi, Thozhukat Sathyapalan, Stephen L. Atkin, Alexandra E. Butler. Severe iatrogenic hypoglycaemia modulates the fibroblast growth factor protein response. Diabetes, Obesity and Metabolism 2022; 24(8): 1483 doi: 10.1111/dom.14716
|
| 7 |
Sachithra S. Ranaweera, Premkumar Natraj, Priyanka Rajan, Laksi A. Dayarathne, Suyama P. Mihindukulasooriya, Duong Thi Thuy Dinh, Youngheun Jee, Chang-Hoon Han. Anti-obesity effect of sulforaphane in broccoli leaf extract on 3T3-L1 adipocytes and ob/ob mice. The Journal of Nutritional Biochemistry 2022; 100: 108885 doi: 10.1016/j.jnutbio.2021.108885
|
| 8 |
Chao Yang, Min Wan, Dengfeng Xu, Da Pan, Hui Xia, Ligang Yang, Guiju Sun. Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis. International Journal of Molecular Sciences 2021; 22(19): 10858 doi: 10.3390/ijms221910858
|